PAHC Stock Overview
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
My Notes
NewNotes are coming soon
Phibro Animal Health Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$15.25 |
52 Week High | US$22.16 |
52 Week Low | US$11.75 |
Beta | 0.53 |
1 Month Change | 13.72% |
3 Month Change | 2.49% |
1 Year Change | -20.98% |
3 Year Change | -35.76% |
5 Year Change | -52.64% |
Change since IPO | -10.29% |
Recent News & Updates
Recent updates
Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12
Nov 05We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed
Oct 26Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?
Aug 26Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
Jul 30Is There An Opportunity With Phibro Animal Health Corporation's (NASDAQ:PAHC) 43% Undervaluation?
Jun 23Is Phibro Animal Health Corporation (NASDAQ:PAHC) A Smart Pick For Income Investors?
Mar 18Phibro Animal Health Corporation (NASDAQ:PAHC) Goes Ex-Dividend Soon
Feb 25We Think Phibro Animal Health (NASDAQ:PAHC) Is Taking Some Risk With Its Debt
Feb 16A Look At Phibro Animal Health's (NASDAQ:PAHC) CEO Remuneration
Jan 29Would Shareholders Who Purchased Phibro Animal Health's (NASDAQ:PAHC) Stock Three Years Be Happy With The Share price Today?
Jan 14Calculating The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Dec 30Should You Or Shouldn't You: A Dividend Analysis on Phibro Animal Health Corporation (NASDAQ:PAHC)
Dec 15Is Phibro Animal Health Corporation (NASDAQ:PAHC) A High Quality Stock To Own?
Nov 30Shareholder Returns
PAHC | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -1.2% | -1.4% | 2.8% |
1Y | -21.0% | 4.5% | -9.2% |
Return vs Industry: PAHC underperformed the US Pharmaceuticals industry which returned 4.5% over the past year.
Return vs Market: PAHC underperformed the US Market which returned -9.2% over the past year.
Price Volatility
PAHC volatility | |
---|---|
PAHC Average Weekly Movement | 4.6% |
Pharmaceuticals Industry Average Movement | 11.1% |
Market Average Movement | 6.9% |
10% most volatile stocks in US Market | 17.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: PAHC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: PAHC's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1946 | 1,860 | Jack Bendheim | https://www.pahc.com |
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Phibro Animal Health Corporation Fundamentals Summary
PAHC fundamental statistics | |
---|---|
Market Cap | US$617.68m |
Earnings (TTM) | US$46.50m |
Revenue (TTM) | US$960.12m |
13.3x
P/E Ratio0.6x
P/S RatioIs PAHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PAHC income statement (TTM) | |
---|---|
Revenue | US$960.12m |
Cost of Revenue | US$670.43m |
Gross Profit | US$289.68m |
Other Expenses | US$243.19m |
Earnings | US$46.50m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 08, 2023
Earnings per share (EPS) | 1.15 |
Gross Margin | 30.17% |
Net Profit Margin | 4.84% |
Debt/Equity Ratio | 177.8% |
How did PAHC perform over the long term?
See historical performance and comparison